Apart from the margins discussion the call covered a lot of known ground but was overall pretty positive.
Without restating the obvious I would add:
1) Michael stated specifically plans being prepared for international expansion FY22 include Europe and Asia
2) He stated re corporate opportunity they are bringing on a specific mgt sales resource to focus on this in Australia (talked about CFA still using pagers but also mining / remote medic etc)
3) talked about looking to add other value add subscription services to Iridium go to broaden the ARR model outside of Zoleo
4) commented on acquisition review and said very committed to current opportunities and would only consider if 1+1 = 3
5) said many times his contacts in US can’t believe only $20m market cap given size of opportunity but said whilst board may consider in the future no immediate plans for US dual listing
not a bad update. Still a strong buy IMO
- Forums
- ASX - By Stock
- BCC
- Beam - Getting to a valuation
BCC
beam communications holdings limited
Add to My Watchlist
14.3%
!
12.0¢

Beam - Getting to a valuation, page-85
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.0¢ |
Change
-0.020(14.3%) |
Mkt cap ! $10.37M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 12.0¢ | $830 | 6.92K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 61094 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 35000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 61094 | 0.120 |
4 | 125290 | 0.110 |
1 | 20000 | 0.095 |
1 | 250000 | 0.093 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 35000 | 1 |
0.140 | 52364 | 1 |
0.145 | 96500 | 1 |
0.150 | 16767 | 1 |
0.155 | 30694 | 1 |
Last trade - 14.30pm 25/06/2025 (20 minute delay) ? |
Featured News
BCC (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online